SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Director/PDMR Shareholding

17 Mar 2022 14:40

RNS Number : 1733F
ConvaTec Group PLC
17 March 2022
Β 

Reading, United KingdomΒ - Thursday 17 March 2022

Β 

ConvaTec Group Plc("ConvaTec" or "the Company")Director/PDMR Shareholding

The Company has been notified of the following transactions by Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 14 March 2022, Karim Bitar, the Company's Chief Executive Officer, and Jonny Mason, the Company's Chief Financial Officer, both Executive Directors, were granted conditional share awards under the Company's Long Term Incentive Plan (LTIP), subject to a time vesting period of three years, performance conditions based on a combination of Adjusted Profit Before Tax growth and Total Shareholder Return, and continued employment, as follows:

Karim Bitar: 1,238,337Jonny Mason: 690,112

Further, on the same day, Karim Bitar was granted 263,650 Shares in accordance with the Company's remuneration policy approved by shareholders, as a result of one third of Mr Bitar's annual bonus being paid out as deferred shares, such shares to vest on the third anniversary of grant. The three-day average share price, closing on 11 March 2022 of 181.13 pence was used in determining the number of shares to be granted under the deferred bonus provisions.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73

b)

Nature of the transaction

1. Grant of conditional share award under the ConvaTec Group Plc Long Term Incentive Plan subject to (i) time vesting period of three years, (ii) performance conditions based on a combination of Adjusted Profit Before Tax growth and Total Shareholder Return and (ii) continued employment

2. Grant of restricted share award under the deferred bonus provisions, subject only to a time-based vesting period of three years.

Β 

c)

Price(s) and volume(s)

Price(s)

1 - n/a

2 - n/a

Volume(s)

1 - 1,238,337

2 - 263,650

d)

Aggregated information

- Aggregated volume

- Price

Β 

n/a

n/a

e)

Date of the transaction

2022-03-14

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/Status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73

b)

Nature of the transaction

Grant of conditional share award under the ConvaTec Group Plc Long Term Incentive Plan subject to (i) time vesting period of three years, (ii) performance conditions based on a combination of Adjusted Profit Before Tax growth and Total Shareholder Return and (ii) continued employment.

Β 

c)

Price(s) and volume(s)

Price(s)

n/a

Volume(s)

690,112

d)

Aggregated information

- Aggregated volume

- Price

Β 

n/a

n/a

e)

Date of the transaction

2022-03-14

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

Β 

Β 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec +44 (0)782 644 7807

ir@convatec.com

Β 

Media

Buchanan: Charles Ryland / Chris Lane Β  +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visitΒ www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFVSVIIDLIF
Date   Source Headline
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20254:45 pmRNSDirector/PDMR Shareholding
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20255:16 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20259:10 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202512:16 pmRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSConvatec commences share buyback programme
18th Aug 202511:09 amRNSHolding(s) in Company
11th Aug 202510:33 amRNSHolding(s) in Company
8th Aug 20257:00 amRNSDirector/PDMR Shareholding
4th Aug 20257:00 amRNSUpdate regarding Chief Executive Officer
1st Aug 202512:18 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSInterim Results
24th Jul 20251:04 pmRNSHolding(s) in Company
15th Jul 20257:34 amRNSConvatec responds to draft CMS proposal
26th Jun 202510:30 amRNSHolding(s) in Company
2nd Jun 20253:45 pmRNSDirector/PDMR Shareholding
22nd May 20254:25 pmRNSResults of AGM
22nd May 20257:00 amRNSAGM Trading Update
29th Apr 20253:15 pmRNSHolding(s) in Company
29th Apr 20252:21 pmRNSHolding(s) in Company
28th Apr 20253:07 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSConvatec responds to LCDs postponement in US
3rd Apr 20253:21 pmRNSHolding(s) in Company
18th Mar 20255:51 pmRNSDirector/PDMR Shareholding
18th Mar 20255:45 pmRNSDirector/PDMR Shareholding
12th Mar 202512:00 pmRNSDirector/PDMR Shareholding
11th Mar 20259:00 amRNSPublication of Annual Report and Notice of AGM
26th Feb 20257:00 amRNSConvatec FY24 Results
15th Nov 202411:53 amRNSHolding(s) in Company
14th Nov 20245:52 pmRNSConvatec responds to LCDs in the United States
12th Nov 20247:00 amRNSTrading update for 10 months ended 31 October 2024
6th Nov 20249:00 amRNSHolding(s) in Company
15th Oct 20249:45 amRNSHolding(s) in Company
19th Aug 20243:17 pmRNSNotification of Major Holdings
2nd Aug 20242:39 pmRNSHoldings in Company
1st Aug 202410:12 amRNSDirector Declaration
30th Jul 20247:00 amRNSInterim Results
20th May 20243:39 pmRNSHolding(s) in Company
16th May 20245:00 pmRNSConvatec Group PLC: Results of AGM
16th May 20247:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.